Contineum Therapeutics, Inc.

Nasdaq:CTNM

Pharmaceutical Preparations·SAN DIEGO, CA

CEO

Stengone Carmine N.

Financials

8 shown

Type	Period	Ended	Filed
10-K	FY 2025	12/31/25	3/5/26	→
10-Q	Q3 2025	9/30/25	10/30/25	→
10-Q	Q2 2025	6/30/25	8/5/25	→
10-Q	Q1 2025	3/31/25	5/14/25	→
10-K	FY 2024	12/31/24	3/6/25	→
10-Q	Q3 2024	9/30/24	11/6/24	→
↓

Earnings Releases (8-K)

9 shown

Filed	Period
3/5/26	Q1 FY2026	→
10/30/25	Q3 FY2025	→
8/5/25	Q3 FY2025	→
5/14/25	Q2 FY2025	→
3/6/25	Q1 FY2025	→
11/6/24	Q4 FY2024	→
↓

News (8-K)

12 shown

Filed	Type	Description
1/26/26	Exec Change	Departure or Appointment of Directors or Certain Officers	→
12/15/25	Agreement	Entry into a Material Definitive Agreement	→
12/11/25	Other	Other Events	→
11/20/25	Other	Other Events	→
9/18/25	Reg FD	Regulation FD Disclosure	→
6/26/25	Vote	Submission of Matters to a Vote of Security Holders	→
↓

Prospectuses & Registrations

12 shown

Filed	Form	Description
3/5/26	S-8	S-8	→
3/5/26	424B5	424B5	→
12/12/25	424B5	424B5	→
12/11/25	424B5	424B5	→
5/14/25	S-8	S-8	→
5/14/25	S-3	S-3	→
↓

Filing History(147 filings)

TypeDateAccessionPeriodSize

S-8

Mar 5, 2026

0001628280-26-015215S-8

—

357.8 KB

424B5

Mar 5, 2026

0001628280-26-015205424B5

—

496.3 KB

10-K

Mar 5, 2026

0001628280-26-01516510-K

Dec 31, 2025

9.1 MB

8-K

Mar 5, 2026

0001628280-26-0151598-K

Mar 5, 2026

393.3 KB

Mar 2, 2026

0001437749-26-006422FORM 4

Mar 2, 2026

5.7 KB

Mar 2, 2026

0001437749-26-006421FORM 4

Mar 2, 2026

8.6 KB

Feb 26, 2026

0001437749-26-005892FORM 4

Feb 24, 2026

13.8 KB

Feb 26, 2026

0001437749-26-005889FORM 4

Feb 24, 2026

14.5 KB

Feb 20, 2026

0001437749-26-004912FORM 4

Feb 19, 2026

8.7 KB

SCHEDULE 13G/A

Feb 17, 2026

0001346824-26-000037

—

14.5 KB

SCHEDULE 13G

Feb 17, 2026

0001274173-26-000079

—

12.1 KB

SCHEDULE 13G

Feb 17, 2026

0001193125-26-052863

—

123.4 KB

Feb 13, 2026

0001437749-26-004126FORM 4

Feb 11, 2026

8.3 KB

Feb 13, 2026

0001437749-26-004122FORM 4

Feb 11, 2026

8.7 KB

144

Feb 11, 2026

0001950047-26-001158

—

7.1 KB

144

Feb 11, 2026

0001950047-26-001156

—

5.1 KB

Feb 5, 2026

0001437749-26-003212FORM 4

Feb 3, 2026

7.6 KB

144

Feb 3, 2026

0001950047-26-000891

—

6.2 KB

Jan 30, 2026

0001437749-26-002579FORM 4

Jan 30, 2026

5.1 KB

Jan 30, 2026

0001437749-26-002578FORM 4

Jan 30, 2026

5.1 KB

Jan 30, 2026

0001437749-26-002577FORM 4

Jan 30, 2026

5.2 KB

Jan 30, 2026

0001437749-26-002576FORM 4

Jan 30, 2026

7.5 KB

Jan 30, 2026

0001437749-26-002575FORM 4

Jan 28, 2026

12.7 KB

SCHEDULE 13G/A

Jan 29, 2026

0000038777-26-000010

—

25.0 KB

8-K

Jan 26, 2026

0001437749-26-002072FORM 8-K

Jan 23, 2026

160.5 KB

25 filings shown

Filed	Form	Description
4/29/25	DEFA14A	FORM DEFA14A	→
4/29/25	DEF 14A	DEF 14A	→

Contineum Therapeutics, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(147 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
3/2/26	4	4	→
3/2/26	4	4	→
2/26/26	4	4	→
2/26/26	4	4	→
2/20/26	4	4	→
2/13/26	4	4	→
↓

Filed	Form	Description
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/17/26	SCHEDULE 13G	SCHEDULE 13G	→
2/17/26	SCHEDULE 13G	SCHEDULE 13G	→
2/11/26	144	144	→
2/11/26	144	144	→
2/3/26	144	144	→
↓